Literature DB >> 24464851

Prediction risk chart for scleroderma digital ulcers: a composite predictive model based on capillaroscopic, demographic and clinico-serological parameters.

Andreina Manfredi1, Marco Sebastiani1, Valeria Carraro2, Michele Iudici3, Mario Bocci4, Gentiana Vukatana5, Roberto Gerli6, Rossella De Angelis7, Patrizia Del Medico8, Emanuela Praino9, Andrea Lo Monaco10, Roberto D'Amico11, Cinzia Del Giovane11, Salvatore Mazzuca12, Michele Colaci1, Dilia Giuggioli1, Clodoveo Ferri1.   

Abstract

BACKGROUND: Digital ulcers (DU) affect 50% of systemic sclerosis (SSc) patients, representing a challenging clinical problem. Despite a high negative predictive value, capillaroscopic scores proposed to select patients at risk for DU show an inadequate positive predictive value, especially in patients without previous DU. AIM OF THIS STUDY: To increase the predictive value for DU development of capillaroscopy, through a predictive risk chart taking into account capillaroscopic, demographic, and clinico-serological parameters. PATIENTS AND METHODS: Two hundred and nineteen unselected SSc patients from 8 Italian Rheumatology Centers were consecutively enrolled during a 6-month period. Demographic, clinical, serological and instrumental data and capillaroscopy skin ulcers risk index (CSURI) were collected.
RESULTS: A multivariate logistic regression analysis showed a significant positive association between DU appearance and male gender, DU history, altered CSURI, and ESR. A prediction risk chart of the development of DU within 6 months were built on the basis of the above parameters. According to the risk level, four risk classes were identified: low (≤19.3%); medium (>19.3%, ≤58.6%); high (>58.6%, ≤89.2%), and very high risk (>89.2%).
CONCLUSIONS: The systematic evaluation of the above parameters can be helpful to identify patients at risk to develop DU optimizing preventive vasoactive therapy.

Entities:  

Keywords:  capillaroscopy; digital ulcers; predictive risk chart; systemic sclerosis

Mesh:

Year:  2015        PMID: 24464851     DOI: 10.3233/CH-141809

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  5 in total

1.  Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.

Authors:  Ivone Silva; Andreia Teixeira; José Oliveira; Isabel Almeida; Rui Almeida; Artur Águas; Carlos Vasconcelos
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 2.  Nailfold capillaroscopy in systemic sclerosis - state of the art: The evolving knowledge about capillaroscopic abnormalities in systemic sclerosis.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  J Scleroderma Relat Disord       Date:  2019-04-15

3.  Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosis.

Authors:  S Friedrich; S Lüders; A M Glimm; S G Werner; G Schmittat; G R Burmester; M Backhaus; G Riemekasten; S Ohrndorf
Journal:  Arthritis Res Ther       Date:  2019-04-15       Impact factor: 5.156

4.  Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study.

Authors:  Maurizio Cutolo; Ariane L Herrick; Oliver Distler; Mike O Becker; Emma Beltran; Patrick Carpentier; Clodoveo Ferri; Murat Inanç; Panayiotis Vlachoyiannopoulos; Harbajan Chadha-Boreham; Emmanuelle Cottreel; Thomas Pfister; Daniel Rosenberg; Juan V Torres; Vanessa Smith
Journal:  Arthritis Rheumatol       Date:  2016-10       Impact factor: 10.995

5.  The first composite score predicting Digital Ulcers in systemic sclerosis patients using Clinical data, Imaging and Patient history-CIP-DUS.

Authors:  S Friedrich; S Lüders; J Klotsche; G R Burmester; G Riemekasten; S Ohrndorf
Journal:  Arthritis Res Ther       Date:  2020-06-15       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.